Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening
Marika Pane, Maria Alice Donati, Costanza Cutrona, et al.
European Journal of Pediatrics (2022) Vol. 181, Iss. 7, pp. 2821-2829
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review
Karolina Aragon‐Gawinska, Charlotte Mouraux, Tamara Dangouloff, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1377-1377
Open Access | Times Cited: 47
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)
Bradford L. Therrell, Carmencita D. Padilla, Gustavo Borrajo, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 2, pp. 38-38
Open Access | Times Cited: 31
Challenges and opportunities in spinal muscular atrophy therapeutics
Crystal Jing Jing Yeo, Eduardo F. Tizzano, Basil T. Darras
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 205-218
Closed Access | Times Cited: 21
The impact of three SMN2 gene copies on clinical characteristics and effect of disease-modifying treatment in patients with spinal muscular atrophy: a systematic literature review
Claudia Dosi, Riccardo Masson
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 9
Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis
Emanuela Abiusi, Alessandro Vaisfeld, Stefania Fiori, et al.
Journal of Medical Genetics (2022) Vol. 60, Iss. 7, pp. 697-705
Closed Access | Times Cited: 29
Longitudinal developmental profile of newborns and toddlers treated for spinal muscular atrophy
M. Ngawa, Fabian Dal Farra, Andrei-Dan Marinescu, et al.
Therapeutic Advances in Neurological Disorders (2023) Vol. 16
Open Access | Times Cited: 14
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy
Gianni Ghetti, Francesco Saverio Mennini, Andrea Marcellusi, et al.
Clinical Drug Investigation (2024) Vol. 44, Iss. 9, pp. 687-701
Open Access | Times Cited: 5
Universal Newborn Screening for Spinal Muscular Atrophy
Maryam Oskoui, Tamara Dangouloff, Laurent Servais
JAMA Pediatrics (2024) Vol. 178, Iss. 6, pp. 520-520
Closed Access | Times Cited: 4
Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience
Delia Gagliardi, Eleonora Canzio, Paola Orsini, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 5, pp. 1090-1096
Open Access | Times Cited: 4
Maximal mouth opening in infants and toddlers with spinal muscular atrophy: a prospective controlled study
Jana Zang, Deike Weiss, Charlotte Dumitrascu, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
The Importance of Early Treatment of Inherited Neuromuscular Conditions
Laurane Mackels, Laurent Servais
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 253-274
Open Access | Times Cited: 3
DySMA – an Instrument to Monitor Swallowing Function in Children with Spinal Muscular Atrophy ages 0 to 24 Months: Development, Consensus, and Pilot Testing
Jana Zang, Stefanie Witt, Jessika Johannsen, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 473-483
Open Access | Times Cited: 3
Deep Molecular Characterization of Milder Spinal Muscular Atrophy Patients Carrying the c.859G>C Variant in SMN2
Laura Campello Blasco, Mar Costa‐Roger, Jordi Leno-Colorado, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8289-8289
Open Access | Times Cited: 14
Spinal Muscular Atrophy
Maryam Oskoui, Laurent Servais
CONTINUUM Lifelong Learning in Neurology (2023) Vol. 29, Iss. 5, pp. 1564-1584
Closed Access | Times Cited: 8
Recommendations for Interpreting and Reporting Silent Carrier and Disease-Modifying Variants in SMA Testing Workflows
John N. Milligan, Laura Campello Blasco, Mar Costa‐Roger, et al.
Genes (2022) Vol. 13, Iss. 9, pp. 1657-1657
Open Access | Times Cited: 12
Motor Outcome Measures in Pediatric Patients with Congenital Muscular Dystrophies: A Scoping Review
Ilaria Cavallina, Rossella D’Alessandro, Chiara Brusa, et al.
Applied Sciences (2023) Vol. 13, Iss. 2, pp. 1204-1204
Open Access | Times Cited: 6
270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10–12 March, 2023, Hoofddorp, the Netherlands
Emanuela Abiusi, Mar Costa‐Roger, Enrico Bertini, et al.
Neuromuscular Disorders (2023) Vol. 34, pp. 114-122
Open Access | Times Cited: 6
Assessing floppy infants: a new module
Costanza Cutrona, Elisa Pede, Roberto De Sanctis, et al.
European Journal of Pediatrics (2022) Vol. 181, Iss. 7, pp. 2771-2778
Open Access | Times Cited: 8
Assessment of Barriers to Referral and Appointment Wait Times for the Evaluation of Spinal Muscular Atrophy (SMA): Findings from a Web-Based Physician Survey
Mary Ann Curry, Rosángel Cruz, Lisa Belter, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 3, pp. 583-598
Open Access | Times Cited: 1
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?
Marika Pane, Giulia Stanca, Chiara Ticci, et al.
European Journal of Pediatrics (2024) Vol. 183, Iss. 7, pp. 2995-2999
Open Access | Times Cited: 1
Why should a 5q spinal muscular atrophy neonatal screening program be started?
Michele Michelin Becker, Flávia Nardes, Tamara Dangouloff, et al.
Arquivos de Neuro-Psiquiatria (2024) Vol. 82, Iss. 10, pp. 1-9
Open Access | Times Cited: 1
Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy—Reply
Oliver Schwartz, Astrid Pechmann, Janbernd Kirschner
JAMA Pediatrics (2024) Vol. 178, Iss. 9, pp. 955-955
Closed Access
Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy
Min-Fang Cheng, Chia‐Hao Hsu
JAMA Pediatrics (2024) Vol. 178, Iss. 9, pp. 954-954
Closed Access
Genetics and”democracy”
Federico Marchetti, Giovanni Corsello
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics (2022) Vol. 48, Iss. 1
Open Access | Times Cited: 1
Can the CHOP-INTEND be used as An Outcome Measure in the First Months of Age? Implications for Clinical Trials and Real World Data
Costanza Cutrona, Roberto De Sanctis, Giorgia Coratti, et al.
Journal of Neuromuscular Diseases (2023) Vol. 11, Iss. 1, pp. 85-90
Open Access
Page 1 - Next Page

Scroll to top